Shōta Imanaga

Shōta Imanaga

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Coordinated international aid rushes to support Jamaica and Cuba after Hurricane Melissa's devastation across the Caribbean.
  • Chargers face offensive line crisis as key players, including first-round pick Joe Alt, suffer season-ending injuries.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Coordinated international aid rushes to support Jamaica and Cuba after Hurricane Melissa's devastation across the Caribbean.
  • Chargers face offensive line crisis as key players, including first-round pick Joe Alt, suffer season-ending injuries.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Shōta Imanaga